Related Experiment Video

Updated: Feb 25, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.6K

Effects of TPX2 gene on radiotherapy sensitization in breast cancer stem cells

Chaoyou Huang1, Zheng Han1, Dehua Wu2

  • 1Department of Breast and Thyroid Surgery, Hexian Memorial Hospital of Panyu, Guangzhou, Guangdong 511400, P.R. China.

Oncology Letters
|August 10, 2017
PubMed

Insights

This study links the Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) gene to breast cancer stem cells. Lovastatin demonstrated significant radiosensitizing effects by influencing TPX2 expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Breast tumor stem cells play a crucial role in tumor development and resistance to therapy.
  • Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) is implicated in cancer progression.
  • Identifying novel radiosensitizers is essential for improving breast cancer treatment outcomes.

Purpose of the Study:

  • To investigate the association between the TPX2 gene and breast tumor stem cells.
  • To screen for potential radiosensitizing agents that can enhance radiotherapy efficacy.
  • To elucidate the mechanism of action of radiosensitizers on breast cancer cells.

Main Methods:

  • Gene and protein expression analysis of TPX2 using Western blot and RT-PCR.
  • Evaluation of radiosensitizing effects of broad-spectrum sensitizers on breast tumor stem cells.
  • Immunohistochemistry to assess treatment efficacy in breast cancer cells.

Main Results:

  • TPX2 gene and protein expression were detected in breast tumor cells and correlated with cancer cell differentiation.
  • Lovastatin at 25 mg/l exhibited the most potent radio-sensitizing effects on breast cancer cells.
  • Immunohistochemical analysis revealed a significant decrease in the positive rate of breast cancer cells treated with lovastatin.

Conclusions:

  • The TPX2 gene is closely associated with the development and progression of breast cancer stem cells.
  • Lovastatin enhances radiosensitivity in breast tumor stem cells through its influence on the TPX2 gene.
  • TPX2 may serve as a potential therapeutic target for improving breast cancer radiotherapy.
Keywords:
breast cancer stem cellslovastatinradiosensitizertargeting protein for Xenopus kinesin-like protein 2 gene

More Related Videos

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.3K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
45
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K